Kevin Kinsella

Kevin Kinsella is the founder of Avalon Ventures. He has specialized in the formation, financing and development of more than 125 early-stage companies, including: Athena Neurosciences Onyx Pharmaceuticals, Inc. [ONXX]; Sequana, Vertex Pharmaceuticals [VRTX], Synaptics [SYNA], Vocera Communications [VCRA], Amira Pharmaceuticals (acquired by BMS), AnaptysBio, JNANA and Eikonizo. Mr. Kinsella was the founding chairman of Athena Neurosciences, Aurora Biosciences, Landmark Graphics, NeoRx, Onyx Pharmaceuticals, Synaptics, Vertex Pharmaceuticals, X-Ceptor and Sequana Therapeutics.